Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.045 CAD
Market Cap: 4.4m CAD

Wall Street
Price Targets

VPH Price Targets Summary
Valeo Pharma Inc

There are no price targets for VPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Valeo Pharma Inc Competitors:
Price Targets
4521
Kaken Pharmaceutical Co Ltd
14% Upside
DPHARMA
Duopharma Biotech Bhd
38% Upside
4887
Sawai Group Holdings Co Ltd
4% Upside
ACAD
ACADIA Pharmaceuticals Inc
12% Upside
NEULANDLAB
Neuland Laboratories Ltd
29% Upside
DMP
Dermapharm Holding SE
16% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
34% Upside
COLL
Collegium Pharmaceutical Inc
3% Downside

Revenue
Forecast

Revenue Estimate
Valeo Pharma Inc

For the last 6 years the compound annual growth rate for Valeo Pharma Inc's revenue is 87%. The projected CAGR for the next 2 years is 14%.

87%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Valeo Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

Net Income Estimate
Valeo Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VPH's stock price target?
Not Available

VPH doesn't have any price targets made by Wall Street professionals.

What is Valeo Pharma Inc's Revenue forecast?
Projected CAGR
14%

For the last 6 years the compound annual growth rate for Valeo Pharma Inc's revenue is 87%. The projected CAGR for the next 2 years is 14%.

Back to Top